1. A method for preparing a particulate composition comprising coenzyme Q10, the method comprising:
combining an organic phase and an aqueous phase, thereby forming an emulsion, wherein the organic phase comprises coenzyme Q10 and a solvent and the aqueous phase comprises a water-soluble encapsulator; and
drying the emulsion, thereby forming a composition comprising solid particles comprising coenzyme Q10.
2. (canceled)
3. The method of claim 2 wherein the solvent comprises an organic solvent is selected from the group consisting of hexanol, ethanol, butanol, heptanol, 2-methyl-1-pentanol, methyl ethyl ketone, acetone, propylene glycol, ethyl acetate, and mixtures thereof.
4-7. (canceled)
8. The method of claim 1 wherein the organic phase comprises a first surfactant having a hydrophile-lipophile balance (HLB) of at least about 8.
9. The method of claim 8 wherein the first surfactant is selected from the group consisting of tocopherol polyethylene glycol succinate, polyvinylpyrrolidone, polyoxyethylene stearate, sodium cholate, deoxycholate, taurocholate, and mixtures thereof.
10. (canceled)
11. The method of claim 8 wherein the first surfactant comprises a polyoxyglyceride selected from the group consisting of lauroyl macroglycerides, stearoyl macroglycerides, and combinations thereof.
12-13. (canceled)
14. The method of claim 1 wherein the organic phase andor aqueous phase further comprises a second surfactant having an HLB of less than about 8.
15-17. (canceled)
18. The method of claim 17 wherein the second surfactant is selected from the group consisting of phosphatidyl choline, phosphatidyl serine, phosphatidyl inositol, phosphatidylglycerol, dioleoyl phosphatidylcholine, dioleoylphosphatidylglycerol, dimyristoylphosphatidylcholine, dipalmitoylphosphatidylcholine, phosphatidylethalolamines, phosphatidylserines, sphingomyelins, poly gylcerol esters, ethoxylated castor oil, a phospholipid derived from soy, a phospholipid derived from milk-fat globule membrane, and mixtures thereof.
19-22. (canceled)
23. The method of claim 1 wherein the encapsulator is selected from the group consisting of polysaccharides, methylcellulose, hydroxypropyl methylcellulose, hydroxyethylcellulose, hydroxypropylethylcellulose, sodium carboxymethylcellulose, crystalline cellulose, ethylcellulose, polyvinylpyrrolidone, pectin, gum arabic, gum tragacanth, acacia, gelatin, and mixtures thereof.
24-32. (canceled)
33. The method of claim 1 wherein the aqueous phase further comprises an organic acid selected from the group consisting of citric acid, succinic acid, ascorbic acid and mixtures thereof.
34. (canceled)
35. The method of claim 33 wherein the aqueous phase further comprises a base selected from the group consisting of sodium bicarbonate, sodium carbonate, sodium hydroxide, and mixtures thereof.
36. (canceled)
37. The method of claim 1 wherein combining the organic phase and the aqueous phase produces an oil-in-water emulsion.
38. The method of claim 8 wherein the emulsion comprises discrete microdroplets of coenzyme Q10 associated with at least one surfactant.
39. The method of claim 38 wherein the discrete microdroplets of coenzyme Q10 have a droplet size distribution such that at least about 50% by weight of the coenzyme Q10 microdroplets have a largest dimension of less than about 20 \u03bcm.
40-43. (canceled)
44-48. (canceled)
49. The method of claim 38 wherein the discrete microdroplets of coenzyme Q10 have a droplet size distribution such that at least about 1% (number basis) of the coenzyme Q10 microdroplets have a largest dimension of less than about 0.5 \u03bcm.
50-62. (canceled)
63. The method of claim 1 wherein the emulsion is dried to form the composition comprising solid particles comprising coenzyme Q10.
64-69. (canceled)
70. The method of claim 1 wherein the solid particles are in the form of colloidal particles comprising discrete microparticulates dispersed throughout a solid matrix comprising the encapsulator, wherein the microparticulates comprise coenzyme Q10 associated with at least one surfactant.
71-87. (canceled)
88. A solid particulate composition comprising coenzyme Q10, a first surfactant having a hydrophile-lipophile balance (HLB) of at least 8, a second surfactant having a hydrophile-lipophile balance (HLB) of less than 8, and a water-soluble encapsulator.
89-117. (canceled)
118. A solid particulate composition comprising coenzyme Q10, wherein the solid particles have a particle size distribution such that at least about 50% by weight of the particles have an overall particle size of from about 8 \u03bcm to about 15 \u03bcm in diameter, and wherein the solid particles are in the form of a water-soluble matrix comprising an encapsulator and having discrete microparticulates of coenzyme Q10 dispersed throughout the water-soluble matrix.
119-151. (canceled)
152. A tablet dosage form comprising a solid particulate composition comprising coenzyme Q10 and one or more biologically acceptable excipients, wherein the particulate coenzyme Q10 composition comprises:
a solid matrix comprising an encapsulator; and microparticulates dispersed throughout the solid matrix, wherein the microparticulates comprise coenzyme Q10, a first surfactant, and a second surfactant.
153-186. (canceled)
187. A formulation for oral administration comprising coenzyme Q10, wherein the total exposure of coenzyme Q10, as determined by the area under the plasma concentration vs. time curve at 4 hours following oral administration of a dose containing about 60 mg of coenzyme Q10, is at least about 0.15 mg\xb7hL.
188-203. (canceled)
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A method of producing a nonwoven material including cellulose fibres and synthetic fibres, which comprises the steps of:
forming the fibres into a fibre web;
subjecting the fibre web to a hydroentanglement step; and
adding a lint-preventing agent to the fibre web through at least one spray nozzle in a step subsequent to the hydroentanglement.
2. The method of producing a nonwoven material according to claim 1, wherein the synthetic fibres are extruded into a web in one step, and the cellulose fibres are wetlaid onto this web in a step preceding the entanglement step.
3. The method of producing a nonwoven material according to claim 1, wherein the cellulose fibres and the synthetic fibres in the form of staple fibres are wetlaid in a step preceding the entanglement step.
4. The method of producing a nonwoven material according to claim 1, wherein the lint-preventing agent is mixed with water before it is sprayed across the fibre web.
5. The method of producing a nonwoven material according to claim 1, wherein the lint-preventing agent is mixed with air before it is sprayed across the fibre web.
6. The method of producing a nonwoven material according to claim 1, further comprising subjecting the fibre web to a corona treatment subsequently to the hydroentanglement step.
7. The method of producing a nonwoven material according to claim 1, wherein the hydroentanglement is performed in two steps: a first step in which the fibre web is hydroentangled from one side; and a second step in which the fibre web is turned and hydroentangled from the other side.
8. The method of producing a nonwoven material according to claim 1, wherein the lint-preventing agent is sprayed on in two steps: a first step in which the fibre web is sprayed from one side; and a second step in which the fibre web is turned and sprayed from the other side.
9. The method of producing a nonwoven material according to claim 1, wherein the lint-preventing agent is poly(amido-amine)-epichlorohydrin (PAE).
10. A nonwoven material in the form of a fibre web or fibre fabric including a lint-preventing agent, which fibre web or fibre fabric exhibits an internal region and a first and a second external region located on both sides of the internal region, and wherein at least the first external region contains more lint-preventing agent than the internal region.
11. The nonwoven material according to claim 10, wherein the lint-preventing agent is poly(amido-amine)-epichlorohydrin (PAE).